Mounjaro 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM4S7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,454
Award facts
- Contract value 100% obligated
- $51,453.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $51,453.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections on November 24, 2025, with completion targeted for November 25, 2025. This is a non-set-aside competitive award utilizing AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as the primary pharmaceutical supply mechanism for Department of Defense healthcare operations. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania.
As a child delivery order under the broader pharmaceutical prime vendor agreement, this award leverages AmerisourceBergen's established capability as a major pharmaceutical distributor to the federal government. Mounjaro is a diabetes medication commonly utilized across military and veteran healthcare systems. The delivery order exemplifies the routine pharmaceutical procurement conducted through DLA's established vendor relationships, enabling rapid fulfillment of medical supply needs for Defense Health Agency beneficiaries and other federal healthcare consumers. AmerisourceBergen's extensive portfolio of federal contract awards demonstrates its critical role in sustaining pharmaceutical supply chains across the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26FM4S7?
SPE2DR26FM4S7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FM4S7 worth?
The government has obligated $51,454 on SPE2DR26FM4S7.
Is contract SPE2DR26FM4S7 an order under another contract?
Yes. SPE2DR26FM4S7 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM4S7 competed?
The extent of competition for SPE2DR26FM4S7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award